CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,513,000 | +748.6% | 42,630 | +97.7% | 0.44% | +553.7% |
| Q1 2016 | $414,000 | -46.9% | 21,560 | -3.1% | 0.07% | -45.5% |
| Q4 2015 | $779,000 | -73.6% | 22,260 | -30.6% | 0.12% | -75.0% |
| Q3 2015 | $2,950,000 | +1.5% | 32,080 | -3.0% | 0.49% | +11.3% |
| Q2 2015 | $2,907,000 | +18.0% | 33,080 | -0.3% | 0.44% | +19.1% |
| Q1 2015 | $2,463,000 | +30.6% | 33,180 | -1.5% | 0.37% | +27.9% |
| Q4 2014 | $1,886,000 | +106.1% | 33,680 | +66.9% | 0.29% | +94.6% |
| Q3 2014 | $915,000 | +36.4% | 20,180 | +24.5% | 0.15% | +30.7% |
| Q2 2014 | $671,000 | +93.9% | 16,210 | +224.2% | 0.11% | +81.0% |
| Q1 2014 | $346,000 | +33.6% | 5,000 | +16.3% | 0.06% | +28.6% |
| Q4 2013 | $259,000 | – | 4,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |